Chargement en cours...
Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
OBJECTIVES: Methotrexate is considered to be first-line therapy for rheumatoid arthritis (RA). However, a substantial proportion of treated patients do not achieve the desired goals of therapy. This analysis aimed to identify predictors of insufficient response to methotrexate in patients with early...
Enregistré dans:
| Publié dans: | Ann Rheum Dis |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225797/ https://ncbi.nlm.nih.gov/pubmed/30076156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2018-213502 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|